IIUM Repository

Dr Fazia Adyani Ahmad Fuad

Profile Picture

Latest Additions

  1. Ahmad Fuad, Fazia Adyani and Tanbin, Suriyea and Ogu Salim, Nurhainis (2022) The glycolytic pathway is a target for drug discovery against tropical diseases. In: The 4th International Conference on Biosciences & Medical Engineering, 21-22 June 2022, IIUM Gombak ( Virtual Conference). (Unpublished)
  2. Azman, Aisya Nazura and Muhd Fahmirauf, Safwan Fathi and Ahmad Fuad, Fazia Adyani and Radin Hisam, Raden Shamilah and Md. Yusuf, Noor Azian (2022) Evaluating the binding interactions between Artemisinin and Kelch 13 protein mutants via molecular modelling and docking studies. Journal of Advanced Research in Applied Sciences and Engineering Technology, 28 (3). pp. 272-286. ISSN 2462-1943
  3. Ahmad Fuad, Fazia Adyani and Ogu Salim, Nurhainis (2022) Analogues of Oxamate, Pyruvate, and Lactate as potential inhibitors of Plasmodium Knowlesi lactate Dehydrogenase identified using virtual screening and verified via Inhibition Assays. Processes, 10 (11). pp. 1-8. ISSN 2227-9717
  4. Tanbin, Suriyea and Ahmad Fuad, Fazia Adyani and Abdul Hamid, Azzmer Azzar (2019) Potential inhibitors of Human Hexokinase II for the development of anti-dengue therapeutics identified via in silico approach. In: Kuliyyah of Engineering Research, Innovation and Commercialization Exhibition 2019 (KERICE 2019), 18th September 2019, KOE, IIUM. (Unpublished)
  5. Ogu Salim, Nurhainis and Ahmad Fuad, Fazia Adyani (2019) In Silico Screening of Inhibitors Against Bacterially Expressed Plasmodium knowlesi Lactate Dehydrogenase Enzyme. In: Kulliiyah of Engineering Research, Innovation, Commercialisation and Exhibition 2019 (KERICE 2019), 18 September 2019, KOE, IIUM. (Unpublished)
  6. Ogu Salim, Nurhainis and Ahmad Fuad, Fazia Adyani (2016) Cloning and characterisation of Lactate Dehydrogenase Gene from Plasmodium knowlesi in bacterial system. In: Borneo Biotech Symposium, 7- 8 December 2016, Kota Kinabalu, Sabah. (Unpublished)
  7. Ogu Salim, Nurhainis and Khairuddin, Farahayu and Jonet, Mohd Anuar and Ahmad Fuad, Fazia Adyani (2018) Cloning and expression of lactate dehydrogenase from plasmodium knowlesi for anti-malarial drug development. In: Asia Pacific Academic Consortium for Public Health Conference, 12-14 Sep 2018, Kota Kinabalu.
  8. Ab Razak, Mohd Zulhakimi and Ahmad Fuad, Fazia Adyani and Abdullah, Azlina and Mohd Nood, Mansor (2019) Stimulating scientific minds among early secondary students in Malaysia: a pilot study  using ‘engineering and electronics made fun’ approach. In: 1st International Conference on STEM Education, 22-24 January 2019, USM Penang. (Unpublished)
  9. Azman, Aisya Nazura and Ahmad Fuad, Fazia Adyani and Md Yusuf, Noor Azian and Zulkefli, Nur Jannah (2021) Computational approaches for evaluation of malaria drug resistance in plasmodium species. In: 6th International Conference of Biotechnology Engineering 2021, 22-23 June 2021, Online. (Unpublished)
  10. Ogu Salim, Nurhainis and Zulrimi, Nurzati Amani and Ahmad Fuad, Fazia Adyani (2016) Potential inhibitors of the glycolytic enzymes from Plasmodium knowlesi identified by virtual screening analysis. In: International Conference of Biotechnology Engineering (ICBioE2016), 25-27 July 2016, Kuala Lumpur.
  11. Che Abdul Aziz, Faqihah Izzati and Ahmad Fuad, Fazia Adyani and Tanbin, Suriyea (2021) Virtual screening and in silico Interactions studies for potential antivirals and diagnostics against the spike protein from the Novel Coronavirus SARS-Cov-2. In: 6th International Conference on Biotechnology Engineering (ICBioE 2021), 22-23 June 2021, Kuala Lumpur (Virtual).
  12. Ogu Salim, Nurhainis and Ahmad Fuad, Fazia Adyani and Khairuddin, Farahayu and Wan Seman, Wan Mohd Khairulikhsan and Jonet, Mohd Anuar (2021) Purifying and characterizing bacterially expressed soluble Lactate Dehydrogenase from Plasmodium knowlesi for the development of anti-malarial drugs. Molecules, 26 (21). E-ISSN 1420-3049
  13. Ahmad Fuad, Fazia Adyani and Tanbin, Suriyea (2021) Enhanced expression and purification strategy for recombinant bacterially-expressed human hexokinase II. Molekul, 16 (1). pp. 82-91. ISSN 1907-9761 E-ISSN 2503-0310
  14. Ahmad Fuad, Fazia Adyani and Tanbin, Suriyea (2020) Interrogating novel compounds for improved anti-dengue therapies via inhibition of human hexokinase II (HKII). In: Nanotechnology Symposium 2020, 21st Feb. 2020, Kuala Lumpur, Malaysia. (Unpublished)
  15. Tanbin, Suriyea and Ahmad Fuad, Fazia Adyani (2020) Novel compounds as potential anti-dengue therapies verified via inhibition of human hexokinase isoform II. In: Kulliyyah of Engineering Research, Innovation and Commercialization Exhibition 2020 (KERICE '20), 8th Dec. 2020, Virtual Platform. (Unpublished)
  16. Tanbin, Suriyea and Mohd Razali, Nur Izzati and Ahmad Fuad, Fazia Adyani (2019) Elucidating the analogues of 3-bromopyruvate (3-BP) as inhibitors against human hexokinase II for the development of anti-dengue drugs. In: 8th International Molecular Biology And Biotechnology Congress (MOLBIOTECH), 17 - 20 Dec 2019, Afyon, Turkey.
  17. Tanbin, Suriyea and Ahmad Fuad, Fazia Adyani and Abdul Hamid, Azzmer Azzar (2021) Virtual screening for potential inhibitors of human hexokinase II for the development of anti-dengue therapeutics. BioTech, 10 (1). pp. 1-28. ISSN 2673-6284
  18. Asman, Nur Atikah and Tanbin, Suriyea and Ahmad Fuad, Fazia Adyani (2020) Effects of Daidzin and analogue of Ganoderma sinense on bacterially-expressed human hexokinase isoform 2 for anti-dengue drug design. Biological And Natural Resources Engineering Journal, 3 (2). pp. 27-34. E-ISSN 2637-0719
  19. Ahammad, Foysal and Tengku Abd Rashid, Tengku Rogayah and Mohamed, Maizan and Tanbin, Suriyea and Ahmad Fuad, Fazia Adyani (2019) Contemporary strategies and current trends in designing antiviral drugs against dengue fever via targeting host-based approaches. Microorganisms, 7 (9). pp. 1-28. ISSN 2076-2607
  20. Ogu Salim, Nurhainis and Md Yusuf, Noor Azian and Ahmad Fuad, Fazia Adyani (2019) Plasmodial enzymes in metabolic pathways as therapeutic targets and contemporary strategies to discover new antimalarial drugs: a review. Asia-Pacific Journal of Molecular Biology and Biotechnology, 27 (4). pp. 38-53. E-ISSN 0128-7451

Most Viewed Items

Item titleViews
1Characterization of conformational and oligomeric states of proteins458
2Inhibitors of leishmania mexicana phosphoglycerate mutase identified by virtual screening and verified by inhibition studies438
3Virtual screening for potential inhibitors of human hexokinase II for the development of anti-dengue therapeutics384
4Identifying analogues of 2-deoxyglucose, alpha-d-glucose and beta-d-glucose-6-phosphate as potential inhibitors of human hexokinase ii for the development of anti-dengue therapeutics373
5Trypanosomatid phosphoglycerate mutases have multiple conformational and oligomeric states368
6Contemporary strategies and current trends in designing antiviral drugs against dengue fever via targeting host-based approaches364
7Potential novel inhibitors of trypanosomatid phosphoglycerate mutases through ligand-based and structure-based in silico approaches357
8Identifying potential inhibitors of human hexokinase II for the development of anti-dengue therapeutics via virtual screening approaches352
9Screening potential inhibitors of lactate dehydrogenase from Plasmodium knowlesi via virtual screening approaches350
10Effects of Daidzin and analogue of Ganoderma sinense on bacterially-expressed human hexokinase isoform 2 for anti-dengue drug design342
11Phosphoglycerate mutase from Trypanosoma brucei is hyperactivated by cobalt in vitro, but not in vivo328
12Super binary vector system enhanced transformation frequency and expression level of polyhydroxyvalerate gene in oil palm immature embryo325
13Expression and purification of soluble bacterially-expressed human hexokinase II in E.coli system317
14Interrogating novel compounds for improved anti-dengue therapies via inhibition of human hexokinase II (HKII)315
15Plasmodial enzymes in metabolic pathways as therapeutic targets and contemporary strategies to discover new antimalarial drugs: a review303
16Multiple oligomeric and conformational states of trypanosomatid phosphoglycerate mutases298
17Novel compounds as potential anti-dengue therapies verified via inhibition of human hexokinase isoform II294
18Elucidating the analogues of 3-bromopyruvate (3-BP) as inhibitors against human hexokinase II for the development of anti-dengue drugs291
19Enhanced expression and purification strategy for recombinant bacterially-expressed human hexokinase II273
20Analogues of 2-Deoxyglucose as inhibitor candidates for hexokinase II identified via virtual screening analyses266
21Purifying and characterizing bacterially expressed soluble Lactate Dehydrogenase from Plasmodium knowlesi for the development of anti-malarial drugs201
22Cloning and expression of lactate dehydrogenase from plasmodium knowlesi for anti-malarial drug development197
23Virtual screening and in silico Interactions studies for potential antivirals and diagnostics against the spike protein from the Novel Coronavirus SARS-Cov-2179
24Cloning and characterisation of Lactate Dehydrogenase Gene from Plasmodium knowlesi in bacterial system136
25Stimulating scientific minds among early secondary students in Malaysia: a pilot study  using ‘engineering and electronics made fun’ approach135
26Potential inhibitors of Human Hexokinase II for the development of anti-dengue therapeutics identified via in silico approach125
27Computational approaches for evaluation of malaria drug resistance in plasmodium species122
28Potential inhibitors of the glycolytic enzymes from Plasmodium knowlesi identified by virtual screening analysis119
29In Silico Screening of Inhibitors Against Bacterially Expressed Plasmodium knowlesi Lactate Dehydrogenase Enzyme104
30Analogues of Oxamate, Pyruvate, and Lactate as potential inhibitors of Plasmodium Knowlesi lactate Dehydrogenase identified using virtual screening and verified via Inhibition Assays12